Deficiency of plasminogen activator inhibitor‐2 results in accelerated tumor growth von Westrick, Randal J., Røjkjær, Lisa Payne, Yang, Angela Y., Roh, Michael H., Siebert, Amy E., Ginsburg, David

Volltext

Variations in Ex-Vivo Assessments of Hemostasis von Gabriel, Don A., Skolnick, Brett E., Rojkjaer, Lisa Payne, Seremetis, Stephanie V.

Volltext

Safety of Recombinant Activated Coagulation Factor VII in Non-Hemophilia Patients von Skolnick, Brett E., Rojkjaer, Lisa Payne, Seremetis, Stephanie V.

Volltext

USE OF FACTOR VII POLYPEPTIDES FOR PREVENTING FORMATION OF INHIBITORS TO BLOOD COAGULATION FACTOR VIII AND IX von LISA, PAYNE ROJKJAER

Volltext bestellen

Use of factor vii polypeptides for preventing formation of inhibitors to blood coagulation factor viii and ix von LISA PAYNE ROJKJAER

Volltext bestellen

Factor VII Polypeptides for Preventing Formation of Inhibitors in Subjects with Haemophilia von JANSEN JENS AAS, ROJKJAER LISA PAYNE, JOHANNESSEN MARIE, NORDFANG OLE JUUL

Volltext bestellen

Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia von JANSEN JENS AAS, ROJKJAER LISA PAYNE, JOHANNESSEN MARIE, NORDFANG OLE JUUL

Volltext bestellen

Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal von SUMNER, M. J., GELDZILER, B. D., PEDERSEN, M., SEREMETIS, S.

Volltext

Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors von Joshi, Ashish V., Stephens, Jennifer M., Munro, Vicki, Mathew, Prasad, Botteman, Marc F.

Volltext